LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Merit Medical Systems Inc

Fermé

SecteurSoins de santé

86.53 1.34

Résumé

Variation du prix de l'action

24h

Actuel

Min

85

Max

86.71

Chiffres clés

By Trading Economics

Revenu

-4.8M

28M

Ventes

1.7M

384M

P/E

Moyenne du Secteur

42.621

77.671

BPA

0.92

Marge bénéficiaire

7.225

Employés

7,400

EBITDA

-4.4M

80M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+17.74% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

27M

4.9B

Ouverture précédente

85.19

Clôture précédente

86.53

Sentiment de l'Actualité

By Acuity

50%

50%

195 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Merit Medical Systems Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 déc. 2025, 22:02 UTC

Résultats

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 déc. 2025, 21:46 UTC

Résultats

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 déc. 2025, 23:52 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 déc. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 déc. 2025, 23:20 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 déc. 2025, 23:15 UTC

Résultats

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 déc. 2025, 22:59 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 déc. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 déc. 2025, 22:40 UTC

Résultats

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 déc. 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 22:06 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 déc. 2025, 22:02 UTC

Résultats

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 déc. 2025, 22:00 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 déc. 2025, 21:53 UTC

Résultats

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 déc. 2025, 21:50 UTC

Acquisitions, Fusions, Rachats

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 déc. 2025, 21:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

10 déc. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 déc. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 déc. 2025, 21:45 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 21:33 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 déc. 2025, 21:32 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 déc. 2025, 21:28 UTC

Acquisitions, Fusions, Rachats

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 déc. 2025, 21:25 UTC

Résultats

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 déc. 2025, 21:18 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 déc. 2025, 21:16 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 déc. 2025, 21:15 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 déc. 2025, 21:15 UTC

Résultats

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 déc. 2025, 21:14 UTC

Résultats

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 déc. 2025, 21:14 UTC

Résultats

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparaison

Variation de prix

Merit Medical Systems Inc prévision

Objectif de Prix

By TipRanks

17.74% hausse

Prévisions sur 12 Mois

Moyen 100.57 USD  17.74%

Haut 109 USD

Bas 90 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

7 ratings

6

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

95.585 / 96.35Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

195 / 374Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat